Background and Objectives The opioid epidemic in the United States has resulted in a
public health emergency. Medication‐assisted treatment (MAT) with methadone and …

Importance The demand for medications for opioid use disorder (MOUD) in rural US
counties far outweighs their availability. Novel approaches to extend treatment capacity …

Background: Having prescribers use clinical video teleconferencing (telemedicine) to
prescribe buprenorphine to people with opioid use disorder (OUD) has shown promise but …

Background Structural vulnerabilities for people who use drugs (PWUD) were exacerbated
by the COVID-19 pandemic. In this context, federal lawmakers in the United States (US) …

Background: A scoping review was conducted to examine the breadth of evidence related to
telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with …

Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be
prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers …

Importance Early COVID-19 mitigation strategies placed an additional burden on individuals
seeking care for opioid use disorder (OUD). Telemedicine provided a way to initiate and …

Objective Opioid use disorder has been declared a public health crisis across North America
and opioid agonist therapy (OAT) is the standard of care for these patients. Despite the …

Objectives: The purpose of this study was to assess the feasibility and clinical impact of
telemedicine-based opioid treatment with buprenorphine-naloxone following the …

Objective Treatment for opioid use disorder (OUD) may include a combination of
pharmacotherapies (such as buprenorphine) with counseling services if clinically indicated …